Literature DB >> 3481319

Ofloxacin in cystic fibrosis.

H Meyer1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3481319     DOI： 10.2165/00003495-198700341-00038

Source DB:  PubMed          Journal:  Drugs        ISSN： 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  1 in total

1.  [A cross-over study on the effectiveness of ofloxacin and ciprofloxacin administered orally].

Authors:  C C Kurz; W Marget; K Harms; R M Bertele
Journal:  Infection       Date:  1986       Impact factor: 3.553
  1 in total
  4 in total

Review 1.  Ofloxacin. A reappraisal of its antimicrobial activity, pharmacology and therapeutic use.

Authors:  P A Todd; D Faulds
Journal:  Drugs       Date:  1991-11       Impact factor: 9.546

Review 2.  Fluoroquinolones: use of clinical data to aid formulary choice by the system of objective judgement analysis (SOJA) method.

Authors:  R Janknegt
Journal:  Pharmacoeconomics       Date:  1994-07       Impact factor: 4.981

Review 3.  Use of quinolones in pediatrics.

Authors:  U B Schaad
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-04       Impact factor: 3.267

Review 4.  Fluoroquinolones in the treatment of cystic fibrosis: a critical appraisal.

Authors:  M LeBel
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-04       Impact factor: 3.267
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.